Cancer is the second worldwide cause of death, exceeded only by cardiovascular diseases.
It is characterized by uncontrolled cell proliferation and an absence of cell death that, except …

Polymeric nanoparticles-based therapeutics show great promise in the treatment of a wide
range of diseases, due to the flexibility in which their structures can be modified, with …

Depending on the context, nanotechnologies developed as nanomedicines (nanosized
therapeutics and imaging agents) are presented as either a remarkable technological …

The field of polymer therapeutics has evolved over the past decade and has resulted in the
development of polymer–drug conjugates with a wide variety of architectures and chemical …

Amphiphilic polymeric nanostructures have long been well-recognized as an excellent
candidate for drug delivery applications. With the recent advances in the “top-down” and …

In the past decade, nanomedicine with its promise of improved therapy and diagnostics has
revolutionized conventional health care and medical technology. Dendrimers and dendrimer …

Nanoscopic vehicles that stably encapsulate drug molecules and release them in response
to a specific trigger are of great interest due to implications in therapeutic applications …

Dendrimers, as a type of artificial polymers with unique structural features, have been
extensively explored for their applications in biomedical fields, especially in drug delivery …

Dendrimers, which are highly branched, multivalent and monodisperse polymers, have
received continuous interest in recent years because of the global demand for new …

Polymeric nanoparticles that can stably load anticancer drugs and release them in response
to a specific trigger such as glutathione are of great interest in cancer therapy. In the present …